JPRN-UMIN000021677已完成未知
the utility of dynamic contrase-enhanced MRI for advanced and metastatic breast cancer administerd with bevacizumab - the utility of dynamic contrase-enhanced MRI for advanced and metastatic breast cancer administerd with bevacizumab
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1)be pregnant or possible to pregnancy 2)with active breast cancer 3)with severe complications 4)with uncontrolled pleural effusion,ascites and edema 5)with brain metastasis 6)doctor's decision not to be registered to this study
研究者
相似试验
进行中（未招募）
1 期
Dynamic contrast enhanced MRI (DCE-MRI) assessment of the vascular changes induced with bevacizumab alone and in combination with interferon-a in patients with advanced renal cell carcinoma. - DCE-MRI changes in tumour vaculature with Bevacizumab and Interferon in advanced RCCPreviously untreated metastatic (stage IV) or locally advanced (inoperable stage III), renal cell carcinomaMedDRA version: 9.1Level: HLTClassification code 10038408Term: Renal cell carcinomasEUCTR2008-006414-19-GBEast and North Hertfordhsire NHS Trust30
尚未招募
不适用
Variability of dynamic contrast-enhanced MRI in the pituitary adenoma: Prospective comparison between gadobutrol and meglumine gadoterate usageKCT0006668Seoul National University Bundang Hospital74
已完成
不适用
DCE-MRI for Assessment of Response to TACE of HCCCarcinoma, HepatocellularNCT02878109Centre hospitalier de l'Université de Montréal (CHUM)40
尚未招募
不适用
The role of non-contrast abbreviated MRI for secondary surveillance of hepatocellular carcinoma after curative treatment: prospective multicenter studyKCT0006395Seoul National University Hospital210
进行中（未招募）
不适用
Differences in dynamic contrast-enhanced (DCE) MRI measurements using Magnevist (Gd-DTPA) and Vas-ovist in patients with untreated squamous cell cervical carcinoma. - NDntreated squamous cell cervical carcinoma(SCCC).MedDRA version: 9.1Level: HLTClassification code 10029109Term: Cervix neoplasmsEUCTR2008-002958-37-ITISTITUTO EUROPEO DI ONCOLOGIA